Cogent Biosciences Ownership | Who Owns Cogent Biosciences?
Cogent Biosciences Ownership Summary
Cogent Biosciences is owned by 110.57% institutional investors, 0.12% insiders. Point72 asset management is the largest institutional shareholder, holding 10.55% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Cogent Biosciences shares.
COGT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cogent Biosciences | 110.57% | 0.12% | -10.70% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Point72 asset management | 10.47M | 10.55% | $88.27M |
Commodore capital lp | 9.74M | 9.81% | $82.09M |
Kynam capital management, lp | 9.26M | 9.33% | $78.07M |
Fmr | 7.69M | 7.75% | $64.86M |
Blackrock | 7.29M | 7.34% | $61.44M |
Tcg crossover management | 6.96M | 7.02% | $58.71M |
Fairmount funds management | 6.23M | 6.27% | $52.48M |
Vr adviser | 5.68M | 5.73% | $47.92M |
Vanguard group | 5.26M | 5.30% | $44.34M |
Redmile group | 4.80M | 4.84% | $40.46M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Tcg crossover management | 6.96M | 6.12% | $58.71M |
Kynam capital management, lp | 9.26M | 6.02% | $78.07M |
Fairmount funds management | 6.23M | 5.93% | $52.48M |
Commodore capital lp | 9.74M | 5.60% | $82.09M |
Saturn v capital management | 1.67M | 5.33% | $14.11M |
Vr adviser | 5.68M | 3.05% | $47.92M |
New leaf venture partners | 250.76K | 2.57% | $2.11M |
Redmile group | 4.80M | 2.45% | $40.46M |
Silverarc capital management | 1.21M | 2.40% | $10.17M |
Vivo capital | 2.24M | 1.75% | $18.92M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | 10.47M | 0.23% | 3.79M |
Paradigm biocapital advisors lp | 3.62M | 1.17% | 3.62M |
Commodore capital lp | 9.74M | 5.60% | 3.31M |
Adage capital partners gp | 4.25M | 0.07% | 2.92M |
Deerfield management company, l.p. (series c) | 3.74M | 0.53% | 2.21M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 3.84M | 0.00% | -3.79M |
Janus henderson group | 15.77K | 0.00% | -2.08M |
Perceptive advisors | - | - | -883.33K |
Morgan stanley | 981.64K | 0.00% | -869.07K |
Readystate asset management lp | - | - | -734.20K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Paradigm biocapital advisors lp | 3.62M | 1.17% | 3.62M | $30.55M |
Franklin resources | 1.00M | 0.00% | 1.00M | $8.43M |
Hennion & walsh asset management | 127.71K | 0.06% | 127.71K | $1.08M |
Alps advisors | 74.60K | 0.00% | 74.60K | $628.86K |
Corebridge financial | 49.37K | 0.00% | 49.37K | $416.16K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -16.00 |
Yhb investment advisors | -50.00 |
Innealta capital | -86.00 |
Us bancorp \de\ | -137.00 |
Quadrant capital group | -689.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 161 | 6.62% | 121,811,557 | 0.36% | 110 | 0.74% | 84 | 6.33% | 46 | -4.17% |
Jun 30, 2024 | 151 | -3.21% | 121,368,548 | 11.09% | 122 | 0.92% | 79 | -20.20% | 48 | 37.14% |
Mar 31, 2024 | 156 | 4.70% | 109,251,854 | 20.30% | 115 | 1.05% | 99 | 2.06% | 35 | 16.67% |
Dec 31, 2023 | 149 | 7.97% | 90,815,313 | -0.05% | 104 | 0.94% | 97 | 38.57% | 30 | -14.29% |
Sep 30, 2023 | 138 | 0.73% | 90,861,407 | 2.34% | 105 | 0.75% | 70 | -10.26% | 35 | -7.89% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 3.29M | 2.98% | 203.35K |
iShares Russell 2000 ETF | 2.37M | 2.17% | -5.33K |
FIAM Small Cap Core CIT Cl B | 1.55M | 1.42% | 20.10K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.54M | 1.40% | -4.81K |
FIAM Small Cap Core Composite | 1.52M | 1.38% | 1.52M |
Eventide Healthcare & Life Sciences I | 1.40M | 1.28% | 1.40M |
Fidelity Series Small Cap Opps | 1.39M | 1.27% | -51.10K |
Fidelity Select Biotechnology | 1.38M | 1.26% | 19.97K |
Fidelity Advisor Biotechnology I | 1.33M | 1.22% | - |
SPDR® S&P Biotech ETF | 1.25M | 1.15% | 13.86K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 09, 2023 | Fairmount Funds Management LLC | - | Buy | $9.60M |
Jun 16, 2022 | Fairmount Funds Management LLC | Buy | $9.90M | |
Apr 26, 2021 | Green John L. | Chief Financial Officer | Sell | $157.82K |
Apr 26, 2021 | Green John L. | Chief Financial Officer | Sell | $157.82K |
Apr 06, 2020 | CAMPANA DARIO | - | Sell | $17.53K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
COGT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools